New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
15:34 EDTARNAArena Pharmaceuticals drops after CHMP issues recommendations
The stock is down over 5.4% at time of writing, edging toward session lows. At the current price of $9.87, next support is at $9.47. Resistance is at the 10-day moving average, last at $10.03.
News For ARNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 25, 2014
09:39 EDTARNAActive equity options trading
Subscribe for More Information
08:06 EDTARNAArena Pharmaceuticals granted patent covering ralinepag
Arena Pharmaceuticals announced that the US Patent and Trademark Office granted Arena U.S. Patent No. 8,895,776, entitled "Modulators of the Prostacyclin Receptor Useful for the Treatment of Disorders Related Thereto," covering ralinepag, an orally available agonist of the prostacyclin, or IP, receptor. Ralinepag is an investigational drug candidate being developed by Arena for the treatment of vasospastic diseases such as pulmonary arterial hypertension.
November 18, 2014
07:37 EDTARNAStifel to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use